Resultados de procura - Songping Zhao

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    Proteases and sFlt-1 Release in the Human Placenta

    Proteases and sFlt-1 Release in the Human Placenta por Songping Zhao, Yang Gu, Ruping Fan, Lynn J. Groome, Dianne Cooper, Y. Wang

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    A highly conserved nuclear gene for low-level phylogenetics: elongation factor-1 alpha recovers morphology-based tree for heliothine moths.

    A highly conserved nuclear gene for low-level phylogenetics: elongation factor-1 alpha recovers morphology-based tree for heliothine moths. por S Cho, Andrew Mitchell, Jerome C. Regier, Charles Mitter, Robert W. Poole, Timothy P. Friedlander, Songping Zhao

    Publicado 1995
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    The Tumor Suppressor Kinase LKB1 Activates the Downstream Kinases SIK2 and SIK3 to Stimulate Nuclear Export of Class IIa Histone Deacetylases

    The Tumor Suppressor Kinase LKB1 Activates the Downstream Kinases SIK2 and SIK3 to Stimulate Nuclear Export of Class IIa Histone Deacetylases por Donald R. Walkinshaw, Ryan Weist, Go-Woon Kim, Linya You, Lin Xiao, Jian‐Yun Nie, Cathy S. Li, Songping Zhao, Minghong Xu, Xiang-Jiao Yang

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes

    Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes por Mukta Ullah, Nadine Pelletier, Lin Xiao, Songping Zhao, Kainan Wang, Cindy Degerny, Soroush Tahmasebi, Christelle Cayrou, Yannick Doyon, Siew-Lee Goh, Nathalie Champagne, Jacques Côté, Xiang-Jiao Yang

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2

    Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2 por Heike Schönherr, Pelin Ayaz, Alexander M. Taylor, Jessica B. Casaletto, B. Barry Touré, Demetri T. Moustakas, Brandi M. Hudson, Roberto Valverde, Songping Zhao, Patrick J. O’Hearn, Lindsey Foster, Dina A. Sharon, Samuel E. Garfinkle, Fabrizio Giordanetto, André Lescarbeau, Ravi Kurukulasuriya, Nastaran Gerami-Moayed, Dejan Maglic, Kamil Bruderek, Gaauri Naik, Hakan Günaydin, Mary M. Mader, Alessandro A. Boezio, Thomas H. McLean, Rongfeng Chen, Yanxia Wang, David E. Shaw, James Watters, Donald A. Bergstrom

    Publicado 2024
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across<i>FGFR2</i>Alterations and Resistance Mutations

    RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across<i>FGFR2</i>Alterations and Resistance Mutations por Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, Kamil Bruderek, B. Barry Touré, Songping Zhao, Roberto Valverde, Patrick J. O’Hearn, Demetri T. Moustakas, Heike Schönherr, Nastaran Gerami-Moayed, Alexander M. Taylor, Brandi M. Hudson, Damian J. Houde, Debjani Pal, Lindsey Foster, Hakan Günaydin, Pelin Ayaz, Dina A. Sharon, Lipika Goyal, Alison M. Schram, Suneel Kamath, Cori Ann Sherwin, Oleg Schmidt‐Kittler, Kai Yu Jen, Fabien Ricard, Beni B. Wolf, David E. Shaw, Donald A. Bergstrom, James Watters, Jessica B. Casaletto

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: